Kodiak Sciences Inc
Veridion Score
Composite trend over time
Why is KOD moving today?
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for KOD.
KOD insider activity
Kodiak Sciences Inc
No multi-insider buying cluster in the last 90 days
Net buying: $58.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 2026-06-04 | BORGESON JOHN A. | Insider | sell | $34.67 | 4,104 | 211,930 | $142K | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | BORGESON JOHN A. | Insider | sell | $34.01 | 25,896 | 216,034 | $881K | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | BORGESON JOHN A. | Insider | buy | $1.04 | 30,000 | 241,930 | $31K | SEC Form 4 |
| 2026-04-16 | 2026-04-15 | BORGESON JOHN A. | Insider | buy | $1.04 | 28,614 | 211,930 | $30K | SEC Form 4 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Insider | sell | $41.77 | 600 | 183,316 | $25K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 7 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moKOD contract awards, year to date.
Public federal awards linked to this ticker.
KOD lobbying filings, year to date.
Registered lobbying filings matched to Kodiak Sciences Inc.